Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguado, M. T., 1993, Future approaches to vaccine development: Single-dose vaccines using controlled-release delivery systems, Vaccine 11:596–597.
Allcock, H. R., 1990, Polyphosphazenes as new biomedical and bioactive materials, in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Marcel Dekker, New York, pp. 163–193.
Allcock, H. R., and Kwon, S., 1989, An ionically cross-linkable polyphosphazene: Poly(bis(carboxylatophenoxy)phosphazene) and its hydrogel and membranes, Macromolecules 22:75–79.
Alonso, M. J., Cohen, S., Park, T. G., Gupta, R. K., Siber, G. R., and Langer, R., 1993, Determinants of release rate of tetanus vaccine from polyester microspheres, Pharm. Res. 10:945–953
Andrianov, A. K., Cohen, S., Visscher, K. B., Payne, L. G., Allcock, H. R., and Langer, R., 1993, Controlled release using ionotropic polyphosphazene hydrogels, J. Controlled Release 27:69–77.
Anik, S. T., Sanders, L. M., Chaplin, M. D., Kushinsky, S., and Nurenberg, C., 1984, Delivery systems for LHRH and analogs, in: LHRH and Its Analogs. Contraceptive and Therapeutic Applications (B. H. Vickery, J. J. Nestor, Jr., and E. S. E. Hafez, eds.), MTP Press, Boston, pp. 421–438.
Arshady, R., 1991, Preparation of biodegradable microspheres and microcapsules: 2. Polylactides and related polyesters, J. Controlled Release 17:1–22.
Artursson, P., Edman, P., Laakso, T., and Sjoholm, I., 1984, Characterization of polyacryl starch microparticles as carriers for proteins and drugs, J. Pharm. Sci. 73:1507–1513.
Asano, M., Fukuzaki, H., Yoshida, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., and Yamanaka, H., 1989a, In vivo characteristics of low molecular weight copoly(D,L-lactic acid) formulations with controlled release of LH-RH agonist, Biomaterials 10:569–573.
Asano, M., Fukuzaki, H., Yoshida, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H., and Suzuki, K., 1989b, In vivo characteristics of low molecular weight copoly(L-lactic acid/glycolic acid) formulations with controlled release of luteinizing hormone-releasing hormone agonist, J. Controlled Release 9:111–122.
Asano, M., Fukuzaki, H., Yoshida, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H., Kawaharada, U., and Suzuki, K., 1991, In vivo controlled release of a luteinizing hormone-releasing hormone agonist from poly(DL-lactic acid) formulations of varying degradation pattern, Int. J. Pharm. 67:61–77.
Aspenberg, P., and Lohmander, S., 1989, Fibroblast growth factor stimulates bone formation, Acta Orthoped Scand 60:473–476.
Baker, R. W., 1987, Controlled Release of Biologically Active Agents, John Wiley & Sons, New York, pp. 1–275.
Bano, M. C., Cohen, S., Allcock, H. R., and Langer, R., 1990, Novel polyphosphazene system for drug delivery and cell microencapsulation, Proc. Int. Symp. Control. Rel. Bioact. Mater. 17:206–207.
Bathurst, I. C., Barr, P. J., Kaslow, D. C., Lewis, D. H., Atkins, T. J., and Rickey, M. E., 1992, Development of a single injection transmission-blocking malaria vaccine using biodegradable microspheres, Proc. Int. Symp. Control. Rel. Bioact. Mater. 19:120–121.
Bernstein, H., Mathiowitz, E., Morrel, E., and Brickner, A., 1993, Erythropoietin drug delivery system, International Patent Application WO 93/25221, date of publication: December 23, 1993
Bhargava, K., and Ando H., 1992, Immobilization of active urokinase onalbumin microspheres: Use of chemical dehydrant and process monitoring, Pharm. Res. 9:776–781.
Bodmer, D., Kissel, T., and Traechslin, E., 1992, Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems, J. Controlled Release 21:129–138.
Brady, J. M., Cutright, D. E., Miller, R. A., and Battistone, G.C., 1973, Resorption rate, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat, J. Biomed. Mater. Res. 7:155–166.
Brems, D. N., 1988, Solubility of different folding conformers of bovine growth hormone, Biochemistry 27:4541–4546.
Brooks, S., Butterworth, K., Christie, R., and Fox, J., 1988, Comparison of the pharmacokinetics of porcine calcitonin in saline and in gelatin diluents in healthy volunteers, Eur. J. Drug Metab. Pharmacokinet. 13:91–97.
Buchner, J. E., and Slade, W. C., 1909, The anhydrides of isophthalic and terephthalic acids, J. Am. Chem. Soc. 31:1319–1321.
Cady, S., Fishbein, R., Schroder, U., Eriksson, H., and Probasco, B., 1993, Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone, US. Patent 5,266,333, November 30, 1993.
Camarata, P. J., Suryanarayanan, R., Turner, D. A., Parker, R. G., and Ebner, T. J., 1992, Sustained release of nerve growth factor from biodegradable polymer microspheres, Neurosurgery 30:313–319.
Cardinal, J., Curatolo, W., and Ebert, C., 1990, Chitosan compositions for controlled and prolonged release of macromolecules, US. Patent 4,895,724, January 23, 1990.
Chasin, M and Langer, R. (eds.), 1990, Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York.
Chasin, M., Domb, A., Ron, E., Mathiowitz, E., Langer, R., Leong, K. W., Laurencin, C., Brem, H., and Grossman, S., 1990, Polyanhydrides as drug delivery systems, in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Marcel Dekker, New York, pp. 43–70.
Choi, N. S., and Heller, J., 1978a, Drug delivery devices manufactured from polyorthoesters and polyorthocarbonates, U.S. Patent 4,093,709, June 6, 1978.
Choi, N. S., and Heller, J., 1978b, Structured orthoesters and orthocarbonate drug delivery devices, U.S. Patent 4,131,648, December 26, 1978.
Choi, N. S., and Heller, J., 1979, Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates), U.S. Patent 4,138,344, December 26, 1979.
Cohen, S., Bano, M. C., Visscher, K. B., Chow, M., Allcock, H. R., and Langer, R., 1990, Ionically cross-linkable polyphosphazene: A novel polymer for microencapsulation, J. Am. Chem. Soc. 112:7832–7833.
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., and Langer, R., 1991, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm Res. 8:713–720.
Conix, A., 1958, Aromatic polyanhydrides, a new class of high melting fibre-formingpolymers, J. Polym. Sci. 29:343–353.
Crommen, J., Vandorpe, J., and Schacht, E., 1993, Degradable polyphosphazenes for biomedical applications, J. Controlled Release 24:167–180.
Dea therage, J., and Miller, E., 1987, Packaging and delivery of bone induction factors in a collagenous implant, Collagen Relat. Res. 7:225–231.
Dittrich, V. W., and Schulz, R. C., 1971, Kinetics and mechanism of the ring-opening polymerization of l-lactide, Angew. Makromol. Chem. 15:109–126.
Doi, Y., Kanesawa, Y., Kunioka, M., and Saito, T., 1990, Biodegradation of microbial copolyesters: Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and poly(3-hydroxybutyrate-co-4-hydroxyvalerate), Macromolecules 23:26–31.
Domb, A. J., and Langer, R., 1987, Polyanhydrides. I. Preparation of high molecular weight polyanhydrides, J. Polym. Sci. 25:3373–3386.
Doolittle, R., 1973, Structural aspects of the fibrinogen to fibrin conversion, Adv. Protein Chem. 27:1–109.
Doolittle, R., 1984, Fibrinogen and fibrin, Annu. Rev. Biochem. 53:195–229.
Dunn, R. L., Tipton, A. J., and Menardi, E. M., 1991, A biodegradable in-situ forming drug delivery system, Proc. Int. Symp. Control. Rel. Bioact. Mater. 18:465–466.
Duysen, E. G., Yewey, G. L., and Dunn, R. L., 1992, Bioactivity of polypeptide growth factors released from the atrigel™ drug delivery system, Pharm. Res. 9:S-73.
Duysen, E. G., Yewey, G. L., Southard, J. L., Dunn, R. L., and Huffer, W., 1993, Release of bioactive growth factors from the artigel™ delivery system in tibial defect and dermal wound models, Pharm. Res. 10:S-83.
Edman, P., Ekman, B., and Sjoholm, I., 1980, Immobilization of proteins in microspheres of biodegradable polyacryldextran, J. Pharm. Sci. 69:838–842.
Eldridge, J. H., Staas, J. K., Meulbroek, J. A,, McGhee, J. R., Tice, T. R., and Gilley, R. M., 1991, Biodegradable microspheres as a vaccine delivery system, Mol. Immunol. 28:287–294.
Engstrom, S., Lindman, B., and Larsson, K., 1992, Method of preparing controlled release preparations for biologically active materials and resulting compositions, U.S. Patent 5,151,272, September 29, 1992.
Eppstein, D. A., 1986, Alternative delivery of interferons, in: Targeting of Drugs with Synthetic Systems (G. Gregoriadis, J. Senior, and G. Poste, eds.), Plenum Press, New York, p.207.
Eppstein, D. A., and Longenecker, J. P., 1988, Alternative delivery systems for peptides and proteins as drugs, Crit. Rev. Ther. Drug Carrier Syst. 5:99–139.
Feijen, J., 1990, Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents, U.S. Patent 4,925,677, May 15, 1990.
Ferguson, T., Harrison, R., and Moore, D., 1986, Injectable sustained release formulation, European Patent Application 0 211 691 A2, date of filing: August 20, 1986.
Frazza, E.J., and Schmitt, E.E., 1971, Anewabsorbablesuture, J. Biomed Mater. Res. Symp. 1:43–58.
Fujioka, K., Sato, S., Sasaki, Y., Miyata, T., Furuse, M., and Naito, H., 1989, Method for producing sustained release formulation, U.S. Patent 4,849,141, July 18, 1989.
Fujioka, K., Sato, S., Tamura, N., Takada, Y., Sasaki, Y., and Maeda, M., 1993, Controlled release formulation, U.S. Patent 5,236,704, August 17, 1993.
Fukuzaki, H., Yoshida, M., Asano, M., Kumakura, M., Yamanaka, H., Mashimo, T., Yuasa, H., Imai, K., Kawaharada, U., and Suzuki, K., 1989, A new biodegradable pasty-type of L-lactic acid and D-valerolactone with relatively low molecular weight for application in drug delivery systems, J. Controlled Release 10:293–303.
Furr, B. J. A., and Hutchinson, F. G, 1992, A biodegradable delivery system for peptides: Preclinical experience with the gonadotrophin-releasing hormone agonist, Zoladex®, J. ControlledRelease 21:117–128.
Ghezzo, E., Benedetti, L., Rochira, M., Biviano, F., and Callegaro, L., 1992, Hyaluronane derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterization, Int. J. Pharm. 87:21–29.
Gilbert, D., and Kim S., 1990, Macromolecular release from collagen monolithic devices, J. Biomed Mater. Res. 24:1221–1239.
Gilbert, D., Okano, T., Miyata, T., and Kim S., 1988, Macromolecular diffusion through collagen membranes, Int. J. Pharm. 47:79–88.
Golumbek, P., Azhari, R., Jaffee. E., Levitsky, H., Lazenby, A., Leong, K., and Pardoll, D., 1993, Controlled release, biodegradable cytokine depots: A new approach in cancer vaccine design, CancerRes. 53:5841–5844.
Goosen, M., Leung, Y., Chou, S., and Sun, A., 1982, Insulin-albumin microbeads: An implantable, biodegradable system, Biomater. Med. Devices Artif: Organs 10:205–218.
Hageman, M. J., Bauer, J. M., Possert, P. L., and Darrington, R. T., 1992, Preformulation studies oriented toward sustained delivery of recombinant somatotropins, J. Agric, Food Chem. 40:348–355.
Hazrati, A. M., Lewis, D. H., Atkins, T. J., Stohrer, R. C., Little, J. E., and Meyer, L., 1992, Studies of controlled delivery tetanus vaccine in mice, Proc. Int. Symp. Control. Rel. Bioact. Mater. 20:367–68.
Heller, J., 1987, Use of polymers in controlled release of active agents, in: Controlled Drug Delivery. Fundamentals and Applications (J. R. Robinson and V. H. L. Lee, eds.), 2nd ed., Marcel Dekker, New York, pp. 180–210.
Heller, J., 1993a, Polymers for controlled parenteral delivery of peptides and proteins, Adv. Drug Delivery Rev. 10:3163–204.
Heller, J., 1993b, Poly(ortho esters), Adv. Polym. Sci. 107:43–92
Heller, J., Penhale, D. W. H., and Helwing, R. F., 1980, Preparation of poly(ortho esters) by the reaction of ketene acetals and polyols, J. Polym. Sci., Polym. Lett. Ed. 18:82–83.
Heller, J., Helwing, R. F., Baker, R. W., and Tuttle, M. E., 1983, Controlled release of water-soluble macromolecules from bioerodible hydrogels, Biomaterials 4:262–266.
Heller, J., Ng, S. Y., Penhale, D. W., Fritzinger, B. K., Sanders, L. M., Burns, R. A., Gaynon, M. G., and Bhosale, S. S., 1987, Use of poly(ortho esters) for the controlled release of 5-fluorouracil and a LHRH analogue, J. Controlled Release, 6:217–224.
Heller, J., Sparer, R. V., and Zentner, G. M., 1990a, Poly(ortho esters) in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Marcel Dekker, New York, pp. 121–161.
Heller, J., Ng, S. Y., Fritzinger, B. K., and Roskos, K. V., 1990b, Controlled drug release from bioerodible hydrophobic ointments, Biomaterials 11:235–237.
Hill, J., and Carothers, W. H., 1932, Studies on polymerization and ring formation. XIV. A linear superpolyanhydride and cyclic dimeric anhydride from sebacic acid, J. Am. Chem. Soc. 54:1569–1579.
Ho, H., and Chen C., 1993, Diffusion characteristics of fibrin film, Int. J. Pharm. 90:95–104
Holland, S. J., Tighe, B. J., and Gould, P. L., 1986, Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems, J. Controlled Release 4:155–180.
Holland, S. J., Jolly, A. M., Yasin, M., and Tighe, B. J., 1987, Polymers for biodegradable medical devices II. Hydroxybutyrate-hydroxyvalerate colpolymers: Hydrolytic degradation studies, Biomaterials 8:289–295.
Hollinger, J. O., and Battistone, G. C., 1986, Biodegradable bone repair materials, Clin. Orthop. Relat. Res. 207:290–305.
Hollinger, J. O., Schmitz, J. P., Mark, D. E., and Seyfer, A. E., 1990, Osseous wound healing with xenogeneic bone implants with a biodegradable carrier, Surgery 107:50–54.
Holmes, P. A., 1985, Applications of PHB—A microbially produced biodegradable thermoplastic, Phys. Technol. 16:32–36.
Hora, M. S., Rana, R. K., Taforo, T. A., Nunberg, J. H., Tice, T. R., Gilley, R. M., and Hudson, M. E., 1989, Development of a controlled release microsphere formulation of interleukin-2, Proc. Int. Symp. Control. Rel. Bioact. Mater. 16:509–510.
Hora, M. S., Rana, R. K., Nunberg, J. H., Tice, T. R., Gilley, R. M., and Hudson, M. E., 1990, Release of human serum albumin from poly(lactide-co-glycolide) microspheres, Pharm. Res. 7:1190–1194.
Hori, R., Komada, F., Iwakawa, S., Seino, Y., and Okumura, K., 1989, Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans, Pharm. Res. 68:13–816.
Horisaka, Y., Okamoto, Y., Matsumoto, N., Yoshimura, Y., Hirano, A., Nishida, M., Kawada, J., Yamashita, K., and Takagi, T., 1994, Histological changes of implanted collagen material during bone induction, J. Biomed. Mater. Res. 28:97–103.
Hsu, C., Nguyen, H., and Wu, S., 1993, Reconstitutable lyophilized protein formulation, U.S. Patent 5,192,743, March 9, 1993.
Hutchinson, F. G., and Furr, B. J. A., 1985, Biodegradable polymers for the sustained release of peptides, Biochem. Soc. Trans. 12:520–523.
Hutchinson, F. G., and Furr, B. J. A., 1987, Biodegradable carriers for the sustained release of polypeptides, TibTech. 5:102–106.
Hutchinson, F. G., and Burr, B. J. A., 1990, Biodegradable polymer systems for the sustained release of polypeptides, J. Controlled Release 13:279–294.
Hutchinson, F. G., and Furr, B. J. A., 1991, Biodegradable polymer systems for the sustained release of polypeptides, in: High Value Polymers (A. H. Fawcett, ed.), Proc. Symp. R Soc. Chem. 87:58–78.
Imasaka, K., Yoshida, M., Fukuzaki, H., Asano, M., Kumakura, M., Mashimo, T., Yamanaka, H., and Nagai, T., 1991, A new biodegradable implant consisting of waxy-type poly(e-caprolactone-co-D-valerolactone) and estramustine, Int. J. Pharm. 68:87–95.
Jamas, S., Ostroff, G., and Easson, D., 1991, Glucan drug delivery system and adjuvant, U.S. Patent 5,032,401, July 16, 1991.
Janoff, A., Popescu, M., Weiner, A., Bolcsak, L., Tremblay, P., and Swenson, C., 1993, Compositions containing tris salt of cholesterol hemisuccinate and antifungal, U.S. Patent 5,231,112, July 27, 1993.
Kawamura, M., and Urist, M., 1988, Human fibrin is a physiologic delivery system for bone morphogenetic protein, Clin. Orthop. Relat. Res. 235:302–310.
Kenley, R. A., Yim, K., Abrams, J., Ron, E., Turek, T., Marden, L. J., and Hollinger, J. O., 1993, Biotechnology and bone graft substitutes, Pharm. Res. 10:1393–1401.
Kent, J., Cholesterol matrix delivery system for sustained release of macromolecules, U.S. Patent 4,452,775, June 5, 1984.
Khan, M., Tucker, I., and Opdebeeck, J., 1993, Evaluation of cholesterol-lecithinimplants for sustained delivery of antigen: Release in vivo and single step immunization of mice, Int. J. Pharm. 90:255–262.
Khan, M. Z. I., Opdebeeck, J. P., and Tucker, I. G., 1994, Immunopotentiation and delivery systems for antigens for single-step immunization: Recent trends and progress, Pharm. Res. 11:2–11.
Kohn, J., Niemi, S. M., Albert, E. C., Murphy, J. C., Langer, R., and Fox, J. G., 1986, Single-step immunization using a controlled release biodegradable polymer with sustained adjuvant activity, J. Immunol. Methods 95:31–38.
Konig, W., Seidel, J. R., and Sandow, J. K., 1985, European Patent Application 0133,988 (C1A61K37/02), March 13, 1985.
Kost, J., and Shefer, S., 1990, Chemically modified polysaccharides for enzymatically controlled oral drug delivery, Biomaterials 11:695–698.
Kulkarni, R. K., Moore, E. G., Hegyelli, A. F., and Leonard, F., 1971, Biodegradable polylactic acid polymers, J. Biomed. Mater. Res. 5:169–181.
Kwon, G., Bae, Y., Cremers, H., Feijen, J., and Kim, S., 1992, Release of proteins via ion exchange from albumin-heparinmicrospheres, J. Controlled Release 22:83–94.
Kwong, A. K., Chou, S., Sun, A. M., Sefton, M. V., and Goosen, M. F. A., 1986, In vitro and in vivo release of insulin from poly(lactic acid) microbeads and pellets, J. Controlled Release 4:47–62.
Langer, R., and Moses, M., 1991, Biocompatible controlled release polymers for delivery of polypeptides and growth factors, J. Cell. Biochem. 45:340–345.
Laurencin, C. T., Koh, H. J., Neenan, T. X., Allcock, H. R., and Langer, R., 1987, Controlled release using a new bioerodible polyphosphazene matrix system, J. Biomed. Mater. Res. 21:1231–1246.
Lee, K. C., Soltis, E. E., Newman, P. S., Burton, K. W., Mehta, R. C., and DeLuca, P. P., 1991, In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres, J. Controlled Release 17:199–206.
Lee, V. H. L., 1991, Trends in peptide and protein drug delivery, Biopharm 1991(March):22–25.
Leong, K. W., and Langer, R., 1987, Polymeric controlled drug delivery, Adv. Drug Delivery Rev. 1:199–233.
Leong, K. W., Brott, B. C., and Langer, R., 1985, Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation and release characteristics, J. Biomed. Mater. Res. 19:945–955.
Leong, K. W., D’Amore, P., Marletta, M., and Langer, R., 1986a, Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity, J. Biomed. Mater. Res. 20:51–64.
Leong, K. W., Kost, J., Mathiowitz, E., and Langer, R., 1986b, Polyanhydrides for controlled release of bioactive agents, Biomaterials 7:364–371.
Leong, K. W., Simonte, V., and Langer, R., 1987, Synthesis of polyanhydrides: Melt-polycondensation, dehydrochlorination, and derivative coupling, Macromolecules 20:705–712.
Lewis, D. H., 1990, Controlled release of bioactive agents from lactide/glycolide polymers, in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Marcel Dekker, New York, pp. 1–41.
Lovell, T. P., Dawson, E. G., Nilsson, O. S., and Urist, M. R., 1989, Augmentation of spinal fusion with bone morphogenetic protein in dogs, Clin. Orthop. Relat. Res. 243:266–274.
Lucas, P., Syftestad, G., Goldberg, V., and Caplan, A., 1989, Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a collagenous delivery vehicle, J. Biomed. Mater. Res.: Appl. Biomater. 23:(A1):23–39.
Lucas, P. A., Laurencin, C., Syftestad, G. T., Domb, A., Goldberg, V. M., Caplan, A. I., and R. Langer, 1990, Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle, J. Biomed. Mater. Res. 24:901–911.
Marshall, L., Patel, K., and Roufa, D., 1991, Controlled release formulations of trophic factors in ganglioside liposome vehicle, U.S. Patent 5073,543, December 17, 1991.
Mathiowitz, E., and Langer, R., 1987, Polyanhydride microspheres as drug carriers I. Hot-melt microencapsulation, J. Controlled Release 5:13–22.
Mathiowitz, E., Leong, K., and Langer, R., 1985, Macromolecular drug release from biodegradable polyanhydride microspheres, Proc. Int. Symp. Control. Rel. Bioact. Mater. 12:183–184.
Mathiowitz, E., Saltzman, W. M., Domb, A., Dor, P., and Langer, R., 1988, Polyanhydride microspheres as drug carriers 11. Microencapsulation by solvent removal, J. Appl. Polym. Sci. 35:755–774.
Mathiowitz, E., Bernstein, H., Morrel, E., and Schwaller, K., 1993, Method for producing protein microspheres, U.S. Patent 5,271,961, December 21, 1993.
Maulding, H. V., 1987, Prolonged delivery of peptides by microcapsules, J. Controlled Release 6:167–176.
Medisorb Technologies International, 1990, Bioabsorbable Polymers, Properties, Uses, Storage and Handling, Medisorb Technical Bulletin.
Miller, E., and Gay, S., 1987, The collagens: An overview and update, Methods Enzymol. 144:3–41.
Mitchell, J., 1985, Prolonged release by biologically active polypeptides, European Patent Application 0 177 478 A2, date of filing: October 3, 1985.
Miyamoto, S., Takaoka, K., Okada, T., Yoshikawa, H., Hashimoto, J., Suzuki, S., and Ono, K., 1992, Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein, Clin. Orthop. Relat. Res. 278:274–285.
O’Hagan, D. T., Rahman, D., McGee, J. P., Jeffery, H., Davies, M. C., Williams, P., Davis, S. S., and Challacombe, S. J., 1991, Biodegradable microparticles as controlled release antigen delivery systems, Immunology 73:239–242.
Okada, H., 1989, One-month release injectable microspheres of leuprolide acetate, a superactive agonist of LHRH, Proc. Int. Symp. Control. Rel. Bioact. Mater. 16:12–13.
Okada, H., Heya, T., Ogawa, Y., and Shimamoto, T., 1988, One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats, J. Pharm. Exp. Ther. 244:744–750.
Okada, H., Inoue, Y., Heya, T., Ueno, H., Ogawa, Y., and Toguchi, H., 1991, Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate, Pharm. Res. 8:787–791.
Ogawa, Y., Okada, H., Yamamoto, M., and Shimamoto, T., 1988, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers, Chem. Pharm. Bull. 36:2576–2581.
Opdebeeck, J., and Tucker I., 1993, A cholesterol implant used as a delivery system to immunize mice with bovine serum albumin, J. Controlled Release 23:271–279.
Papini, D., Stella, V., and Topp, E., 1993, Diffusion of macromolecules in membranes of hyaluronic acid esters, J. Controlled Release 27:47–57.
Park, K., Shalaby, W., and Park, H., 1993, Biodegradable Hydrogels for Drug Delivery, Technomic Publishing, Basle.
Physicians’ Desk Reference, 1994, 48th ed., Medical Economics Data Production Company, Montvale, New Jersey.
Piez, K., 1985, Encyclopedia of Polymer Science and Engineering, Vol. 3, 2nd ed., John Wiley & Sons, New York, pp. 699–727.
Pitt, C., 1990a, The controlled parenteral delivery of polypeptides and proteins, Int. J. Pharm. 59:173–196.
Pitt, C. G., 1990b, Poly-e-caprolactone and its copolymers, in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Marcel Dekker, New York, pp. 71–120.
Pitt, C. G., 1992, Non-microbial degradation of polyesters: Mechanisms and modifications, in: Biodegradable Polymers and Plastics (M. Vert, J. Feijen, A. Albertsson, G. Scott, and E. Chiellini, eds.), Royal Society of Chemistry, Cambridge, pp. 7–19.
Pitt, C. G., Cha, Y., Hendren, R. W., Holloman, M., and Schindler, A., 1987, Manipulation of the permeability and degradability of polymers, Proc. Int. Symp. Control. Rel. Bioact. Mater. 14:75–76.
Prisell, P., Camber, O., Hiselius, J., and Norstedt, G., 1992, Evaluation of hyaluronan as a vehicle for peptide growth factors, Int. J. Pharm. 85:51–56.
Pulapura, S., Li, C., and Kohn, J., 1990, Structure-property relationships for the design of polyiminocarbonates, Biomaterials 11:666–678.
Radomsky, M. L., Brouwer, G., Floy, B. J., Loury, D. J., Chu, F., Tipton, A. J., and Sanders, L. M., 1993, The controlled release of Ganirelix from the Atrigel™ injectable implant system, Proc. Int. Symp. Control. Rel. Bioact. Mater. 20:458–459.
Raghuvanshi, R. S., Singh, M., and Talwar, G. P., 1993, Biodegradable delivery system for single step immunization with tetanus toxoid, Int. J. Pharm. 93:R1–R5.
Ron, E., Turek, T., Mathiowitz, E., Chasin, M., and Langer, R., 1989, Release of polypeptides from poly(anhydride) implants, Proc. Int. Symp. Control. Rel. Bioact. Mater. 16:338–339.
Ron, E., Turek, T., Mathiowitz, E., Chasin, M., Hageman, M., and Langer, R., 1993, Controlled release of polypeptides from polyanhydrides, Proc. Natl. Acad. Sci. USA 90:4176–4180.
Rosen, H. G., Chang, J., Wnek, G. E., Linhardt, R. J., and Langer, R., 1983, Bioerodible polyanhydrides for controlled drug delivery, Biomaterials 4:31–133.
Rosenblatt, J., Rhee, W., and Wallace, D., 1989, The effect of collagen fiber size distribution on the release rate of proteins from collagen matrices by diffusion, J. Controlled Release 9:195–203.
Royer, G., Lee, T., and Sokoloski, T., 1983, Entrapment of bioactive compounds within native albumin beads, J. Pharm. Sci. Technol. 37:34–37.
Sah, H. K., and Chien, Y. W., 1993, Evaluation of a microreservoir-type biodegradable microcapsule for controlled release of proteins, Drug Dev. Ind. Pharm. 19:1243–1263.
Sanders, L. M., 1990, Controlled delivery systems for peptides, in: Peptide and Protein Drug Delivery (V. H. L. Lee, ed.), Marcel Dekker, New York, pp. 785–806.
Sanders, L. M., Kent, J. S., McRae, G. I., Vickery, B. H., Tice, T. R., and Lewis, D. H., 1984, Controlled release of luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide), J. Pharm. Sci. 73:1294–1297.
Sanders, L. M., McRae, G. I., Vitale, K. M., and Kell, B. A., 1985, Controlled delivery of an LHRH analogue from biodegradable injectable microspheres, J. Controlled Release 2:187–195.
Sanders, L. M., Kell, B. A,, McRae, G. I., and Whitehead, G. W., 1986, Prolonged controlled-release of Nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: Influence of composition and molecular weight of polymer, J. Pharm. Sci. 75:356–360.
Schindler, A., Porous bioabsorbable polyesters as controlled-release reservoirs for high molecular weight drugs, European Patent Application EP 223708 A2, May 27, 1987.
Schmitz, J. P., and Hollinger, J. O., 1988, A preliminary study of the osteogenic potential of a biodegradable alloplastic-osteoinductive alloimplant, Clin. Orthop. Relat. Res. 237:245–255.
Schroder, U., 1984, A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof, International Patent Application WO 84/00294, date of publication: February 2, 1984.
Senderoff, R., Sheu, M., and Sokoloski, T., 1991, Fibrin based drug delivery systems, J. Parenter. Sci. Technol. 45:2–6.
Shah, N. H., Railkar, A. S., Chen, F. C., Tarantino, R., Kumar, S., Murjani, M., Palmer, D., Infeld, M. H., and Malick, A. W., 1993, A biodegradable injectable implant for delivering micro and macromolecules using poly(lactic-co-glycolic) acid (PLGA) copolymers, J. Controlled Release 27:139–147.
Shah, S. S., Cha, Y., and Pitt, C. G., 1992, Poly(glycolic acid-co-lactic acid): Diffusion or degradation controlled drug delivery?, J. Controlled Release 18:261–270.
Singh, M., Singh, A., and Talwar, G. P., 1991a, Controlled delivery of diphtheria toxoid using biodegradable poly(d,l-lactide) microcapsules, Pharm. Res. 8:958–961.
Singh, M., Rathi, R., Singh, A., Heller, J., Talwar, G. P., and Kopecek, J., 1991b, Controlled release of LHRH-DT from bioerodible hydrogel microspheres, Int. J. Pharm. 76:R5–R8.
Singh, M., Singh, O., Singh, A., and Talwar, G. P., 1992, Immunogenicity studies on diphtheria toxoid loaded biodegradable microspheres, Int. J. Pharm. 85:R5–R8.
Sivaramakrishnan, K., and Miller, L., 1990, Controlled release delivery device for macromolecular proteins, International Patent Application WO 90/11070, date of publication: October 4, 1990.
Sivaramakrishnan, K., and Miller, L., 1993, Controlled release delivery device for macromolecular proteins, United States Patent 5, 219, 572, June 15, 1993.
Song, S., and Morawiecki, A., 1993, Collagen containing sponges as drug delivery for proteins, European Patent Application 0 568 334 A1, date of filing: April 28, 1993.
Steber, W., Fishbein, R.M. and Cady, S., 1987, Compositions for parenteral administration and their use, European Patent Application 0 257 368 A1, date of filing: August 4, 1987.
Stevens, V. C., Powell, J. E., Lee, A. E., Kaumaya, P. T. P., Lewis, D. H., Rickey, M., and Atkins, T. J., 1992, Development of a delivery system for a birth control vaccine using biodegradable microspheres, Proc. Int. Symp. Control. Rel. Bioact. Mater. 19:112–113.
Tabata, Y., and Ikada, Y., 1989, Synthesis of gelatin microspheres containing interferon, Pharm. Res. 64:22–427.
Tabata, Y., and Langer, R., 1993, Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds, Pharm Res. 10:391–399.
Tabata, Y., Takebayashi, Y., Ueda, T., and Ikada, Y., 1993a, A formulation method using D,L-lactic acid oligomer for protein release with reduced initial burst, J. Controlled Release 23:55–64.
Tabata, Y., Gutta, S., and Langer, R., 1993b, Controlled delivery systems for proteins using polyanhydride microspheres, Pharm Res. 10:487–496.
Tadmor, Z., and Gogos, C. G., 1979, Principles of Polymer Processing, John Wiley & Sons, New York.
Takaoka, K., Koezuka, M., and Makahara, H., 1991, Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein, J. Orthoped. Res. 9:902–907.
Torchilin, V. P., Tischenko, E. G., Smirnov, V. N., and Chazov, E. I., 1977, Immobilization of enzymes on slowly soluble carriers, J. Biomed. Mater. Res. 11:223–235.
Toriumi, D. M., Kotler, H. S., Luxenberg, D. P., Holtrop, M. E., and Wang, E. A., 1991, Mandibular reconstruction with a recombinant bone-inducing factor, Arch Otolaryngol. Neck Surg 177:1101–1121.
Wallace, D., McPherson, J., Ellingsworth, L., Cooperman L., Armstrong R., and Piez K., 1988, Injectable collagen for tissue augmentation, in: Collagen, Vol. 3 (M. E. Nimni, ed.), CRC Press, Boca Raton, Florida, pp. 117–141.
Wang, H. T., Schmitt, E., Flanagan, D. R., and Linhardt, R. J., 1991, Influence of formulation methods on the in vitro controlled release of protein from poly(ester) microspheres, J. Controlled Release 17:23–32.
Wang, P., 1987, Prolonged release of insulin by cholesterol-matrix implant, Diabetes 36:1068–1072.
Waxman, J. H., Sandow, J., Magill, P. J. and Oliver, R. T. D., 1985, Symposium on Treatment Advances: Prostatic Cancer Role LHRH-Superagonists, Baden, June 1985.
Weiner, A., Carpenter-Green, S., Soehngen, E., Lenk, R., and Popescu, M., 1985, Liposome-collagen gel matrix: A novel sustained drug delivery system, J. Pharm. Sci. 74:922–925.
Williams, D. F., 1987, Definitions in Biomaterials, Proceedings of a Consensus Conference of the European Society for Biomaterials, Elsevier, Amsterdam.
Wise, D. L., Trantolo, D. J., Marino, R. T., and Kitchell, J. P., 1987, Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines, Adv. Drug Delivery Rev. 1:19–39.
Wuthrich, P., Ng, S. Y., Fritzinger, B. K., Roskos, K. V., and Heller, J., 1992, Pulsatile and delayed release of lysozyme from ointment-like poly(ortho esters), J. Controlled Release 21:191–200.
Yamahira, Y., Fujioka, K., Sato, S., and Yoshida, N., 1984, Sustained release preparation, European Patent Application 0 138 216 A2, date of filing: October 12, 1984.
Yamahira, Y., Fujioka, K., Sato, S., and Takada, Y., 1988, Long term sustained release preparation, U.S. Patent 4,774,091, September 27, 1988.
Yamahira, Y., Fujioka, K., and Sato, S., 1989, Sustained release preparation, U.S. Patent 4,855,134, August 3, 1989.
Yamazaki, H., Miyazaki, M., and Matsumoto, K., 1992, Cellulosic wound dressing with an active agent ionically absorbed thereon, U.S. Patent 5,098,417, March 24, 1992.
Yan, C., Hewetson, J., Creasia, D., Nelson, E., Rill, W., Tammariello, R., Mereish, K., and Kende, M., 1993, Enhancement of ricin toxoid efficacy by controlled rate-release from microcapsules, Proc. Int. Symp. Control. Rel. Bioact. Mater. 20:71–72.
Yasko, A. W., Lane, J. M., Fellinger, E. J., Rosen, V., Wozney, J. M., and Wang, E. A., 1992, The healing of segmental defects induced by recombinant human bone morphogenetic protein-2, J. Bone Joint Surg. 74-A:659–671.
Yewey, G. L., Duysen, E. G., Southard, J. L., and Dum, R. L., 1993, Controlled release of growth factors from a biodegradable delivery system, in: Portland Bone Symposium 1993 (J. Hollinger and A. E. Seyfer, eds.), Oregon Health Sciences University, Portland, pp. 453–454
Yoda, N., 1963, Syntheses of polyanhydrides. XII. Crystalline and high melting polyamide-polyanhydride of methylenebis(p-carboxyphenyl) amide, J. Polym. Sci. Part A 1323–1338.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Roskos, K.V., Maskiewicz, R. (2002). Degradable Controlled Release Systems Useful for Protein Delivery. In: Sanders, L.M., Hendren, R.W. (eds) Protein Delivery. Pharmaceutical Biotechnology, vol 10. Springer, Boston, MA. https://doi.org/10.1007/0-306-46803-4_2
Download citation
DOI: https://doi.org/10.1007/0-306-46803-4_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45359-5
Online ISBN: 978-0-306-46803-2
eBook Packages: Springer Book Archive